Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis

• Andrés Pichon-Riviere ,

  * E-mail: apichon@iecs.org.ar

  Affiliation Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy (IECS). Buenos Aires, Argentina

  ⨯
• Demián Glujovsky,

  Affiliation Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy (IECS). Buenos Aires, Argentina

  ⨯
• Osvaldo Ulises Garay,

  Affiliation Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy (IECS). Buenos Aires, Argentina

  ⨯
• Federico Augustovski,

  Affiliation Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy (IECS). Buenos Aires, Argentina

  ⨯
• Agustin Ciapponi,

  Affiliation Department of Health Technology Assessment and Economic Evaluation, Institute for Clinical Effectiveness and Health Policy (IECS). Buenos Aires, Argentina

  ⨯
• Magdalena Serpa,

  Affiliation Maternal and Child Health Integrated—Program (MCHIP)—PATH, Washington, D. C., United States of America

  ⨯
• Fernando Althabe

  Affiliation Mother and Child Health Research Department, Institute for Clinical Effectiveness and Health Policy (IECS). Buenos Aires, Argentina

  ⨯